Cargando…

Correction to: An update on the CNS manifestations of neurofibromatosis type 2

Detalles Bibliográficos
Autores principales:	Coy, Shannon, Rashid, Rumana, Stemmer-Rachamimov, Anat, Santagata, Sandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096359/ https://www.ncbi.nlm.nih.gov/pubmed/31432207 http://dx.doi.org/10.1007/s00401-019-02044-6

Ejemplares similares

An update on the CNS manifestations of neurofibromatosis type 2
por: Coy, Shannon, et al.
Publicado: (2019)

Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
por: Kukutla, Phanidhar, et al.
Publicado: (2021)

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
por: Prabhakar, Shilpa, et al.
Publicado: (2022)

Correction: Stochastic Model of Tsc1 Lesions in Mouse Brain
por: Prabhakar, Shilpa, et al.
Publicado: (2013)

Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
por: Stivaros, Stavros M, et al.
Publicado: (2015)

Correction to: Olipudase Alfa in Non-CNS Manifestations of Acid Sphingomyelinase Deficiency: A Profile of Its Use
por: Syed, Yahiya Y.
Publicado: (2023)

Correction: Neurofibromatosis Type 1 and the “Elephant Man's” Disease: The Confusion Persists: An Ethnographic Study
por: Legendre, Claire-Marie, et al.
Publicado: (2011)

Correction: Neurofibromatosis Type 1 and the “Elephant Man's” Disease: The Confusion Persists: An Ethnographic Study
por: Legendre, Claire-Marie, et al.
Publicado: (2011)

Bone Manifestations of Neurofibromatosis Type 1
por: Diallo, Ibrahima Dokal, et al.
Publicado: (2022)

Correction to: Management of spinal deformities and tibial pseudarthrosis in children with neurofibromatosis type 1 (NF-1)
por: Mladenov, Kiril V., et al.
Publicado: (2021)

Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Tamura, Ryota, et al.
Publicado: (2020)

Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2
por: Jordan, Justin T, et al.
Publicado: (2023)

Correction: Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden
Publicado: (2015)

Oncologic manifestations of neurofibromatosis type 1 in Korea
por: Kim, Eui Tae, et al.
Publicado: (2012)

Abdominal neoplastic manifestations of neurofibromatosis type 1
por: Dare, Anna J, et al.
Publicado: (2020)

Correction: Neurofibromatosis Type 2 Tumor Suppressor Protein, NF2, Induces Proteasome-Mediated Degradation of JC Virus T-Antigen in Human Glioblastoma
por: Beltrami, Sarah, et al.
Publicado: (2013)

Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
por: Isakson, Sara H., et al.
Publicado: (2018)

Correction: Maximizing lentiviral vector gene transfer in the CNS
por: Humbel, Morgane, et al.
Publicado: (2022)

Correction: Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization
por: Weng, Qinjie, et al.
Publicado: (2020)

Dural ectasia: a manifestation of type 1 neurofibromatosis
por: Derdabi, Ilyas, et al.
Publicado: (2018)

Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments
por: Poplausky, Dina, et al.
Publicado: (2023)

An Update on Neurofibromatosis Type 1-Associated Gliomas
por: Lobbous, Mina, et al.
Publicado: (2020)

Correction: Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1
por: Faden, Daniel L., et al.
Publicado: (2017)

Decreased Vision and Junctional Scotoma from Pituicytoma
por: Huynh, Nancy, et al.
Publicado: (2012)

Author Correction: Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
por: Well, Lennart, et al.
Publicado: (2021)

Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas
por: Carrió, Meritxell, et al.
Publicado: (2019)

Spontaneous pneumothorax as a clinical manifestation of neurofibromatosis type 1
por: Lorentzen, Tine, et al.
Publicado: (2021)

Orthopaedic manifestations of neurofibromatosis type 1: A case report
por: Năstase, Florentina, et al.
Publicado: (2022)

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2
por: Allaway, Robert, et al.
Publicado: (2018)

Central nervous system manifestations of neurofibromatosis type 2: A case report
por: Izi, Zineb, et al.
Publicado: (2023)

Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting
por: Kalamarides, Michel, et al.
Publicado: (2011)

Correction: In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
por: Wildsmith, Kristin R., et al.
Publicado: (2012)

Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
por: Miller, Shyra J, et al.
Publicado: (2009)

Retrospective Multicentric Study on Non-Optic CNS Tumors in Children and Adolescents with Neurofibromatosis Type 1
por: Santoro, Claudia, et al.
Publicado: (2020)

Correction: Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1)
Publicado: (2021)

Spontaneous rupture of an arachnoid cyst in an adult: illustrative case
por: Leavitt, Lydia A., et al.
Publicado: (2023)

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
por: Legius, Eric, et al.
Publicado: (2021)

Correction: Cardiovascular Variability Analysis and Baroreflex Estimation in Patients with Type 2 Diabetes in Absence of Any Manifest Neuropathy
por: de Moura-Tonello, Sílvia Cristina Garcia, et al.
Publicado: (2017)

Minimal intervention for neurofibromatosis type I manifestations: A case report
por: Saad, Reem Hassan, et al.
Publicado: (2023)

Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification
por: Keck, Michaela-Kristina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_abmcjhiqn50si12uugb1njbluh